Vaccines against Viral & Bacterial Diseases
Most vaccines against viral infection are effective at preventing disease. However, they are not 100% effective for a number of reasons, reactions can occur after vaccinations.
It is difficult for many of us today to appreciate the dangers of childhood viral infections.
Most of the vaccines in use against viruses are very effective at preventing disease. However, for a variety of reasons, they can fail:
- The vaccine becomes inactive due to incorrect storage, if used past its expiry date, or if incorrectly administered.
- Individuals unpredictably fail to produce an adequate immune response to the vaccine.
- Vaccine immunity “fades” over time.
The different vaccine combinations at each time point do not interfere with one another and there is no increased risk of serious side-effects when they are given at the same time.
Bacterial vaccines contain killed or attenuated bacteria that activate the immune system. Antibodies are built against that particular bacteria, and prevents bacterial infection later.
Most vaccines against bacterial infections are effective at preventing disease, reactions can occur after vaccinations. Vaccines are available against tuberculosis, diphtheria, tetanus, pertussis, Haemophilus influenzae type B, cholera, typhoid, and Streptococcus pneumoniae.
- Mumps, measles and rubella/MMR Vaccines
- Live attenuated vaccines
- Typhus Vaccine
- Typhoid Vaccines
- HSV vaccines
- Rabies Vaccines
- Viral hepatitis
- Shingles
- Inactivated vaccines
Related Conference of Vaccines against Viral & Bacterial Diseases
7th International Conference on Vaccines, Immunology and Clinical Trials
Vaccines against Viral & Bacterial Diseases Conference Speakers
Recommended Sessions
- Cancer Vaccines and Immunotherapy
- Childhood and Maternal Vaccines
- DNA Vaccines
- Hepatitis Vaccines
- HIV/AIDS Vaccines
- HPV Vaccines
- Human Preventive & Therapeutic Vaccines
- Human Vaccines - Infectious & Non Infectious Diseases
- Immunology/Animal Models
- Mucosal Vaccines
- Next-Generation Vaccines Delivery Technologies
- Plant-based Vaccines
- Travel Immunization
- Vaccine Adjuvants
- Vaccine Research & Development
- Vaccine Safety & Efficacy
- Vaccines against Vector-borne Diseases
- Vaccines against Viral & Bacterial Diseases
- Vaccines Business Development
- Vaccines for Older Adults
- Vaccines for Respiratory Diseases
- Veterinary Vaccines
Related Journals
Are you interested in
- Antiviral Therapies - Virology 2024 (Austria)
- Basic Immunology - Virology 2024 (Austria)
- Cancer Vaccines - Vaccine Congress 2024 (Spain)
- Challenges in Global Vaccination Programs - Vaccines R&D 2024 (Netherlands)
- Chicken pox Vaccines - Vaccine Congress 2024 (Spain)
- Clinical Immunology - Virology 2024 (Austria)
- Clinical Trials: Safety, Efficacy, and Beyond - Vaccines R&D 2024 (Netherlands)
- Component Vaccines - Vaccine Congress 2024 (Spain)
- COVID-19 Vaccine - Vaccine Congress 2024 (Spain)
- Cutting-Edge Techniques in Vaccine Manufacturing - Vaccines R&D 2024 (Netherlands)
- Ebola Vaccines - Vaccine Congress 2024 (Spain)
- Emerging Viral Diseases - Virology 2024 (Austria)
- Epidemiology and Public Health - Virology 2024 (Austria)
- Gene Editing for Vaccine Development - Vaccines R&D 2024 (Netherlands)
- HIV Vaccines - Vaccine Congress 2024 (Spain)
- Human Papilloma Virus Vaccine - Vaccine Congress 2024 (Spain)
- Immune System and Non-Infectious Diseases - Vaccines R&D 2024 (Netherlands)
- Immunogenetics and Genomics - Virology 2024 (Austria)
- Immunology and Infectious Diseases: Current Landscape - Vaccines R&D 2024 (Netherlands)
- Immunology of Aging and Vaccination - Vaccines R&D 2024 (Netherlands)
- Immunometabolism - Virology 2024 (Austria)
- Immunotherapy - Virology 2024 (Austria)
- Immunotherapy: Novel Strategies and Technologies - Vaccines R&D 2024 (Netherlands)
- Infectious Diseases and Immunity - Virology 2024 (Austria)
- Inflammation and Immune Response - Virology 2024 (Austria)
- Innovative Approaches to Vaccine Design - Vaccines R&D 2024 (Netherlands)
- MMR Vaccines - Vaccine Congress 2024 (Spain)
- Next-Generation Vaccines: Advancements and Challenges - Vaccines R&D 2024 (Netherlands)
- Polio Vaccines - Vaccine Congress 2024 (Spain)
- Precision Medicine and Personalized Vaccines - Vaccines R&D 2024 (Netherlands)
- Preclinical Vaccine Studies - Vaccine Congress 2024 (Spain)
- Public-Private Partnerships for Vaccine Research - Vaccines R&D 2024 (Netherlands)
- Regulatory Guidelines for Vaccine Approval - Vaccines R&D 2024 (Netherlands)
- The Future of Vaccinology: Trends and Prospects - Vaccines R&D 2024 (Netherlands)
- Vaccine Adjuvants - Vaccine Congress 2024 (Spain)
- Vaccine Development - Virology 2024 (Austria)
- Vaccine Hesitancy: Causes and Solutions - Vaccines R&D 2024 (Netherlands)
- Vaccine Regulatory Issues - Vaccine Congress 2024 (Spain)
- Vaccine Research & Development - Vaccine Congress 2024 (Spain)
- Vaccines Epidemiology - Vaccine Congress 2024 (Spain)
- Vaccines Immunology - Vaccine Congress 2024 (Spain)
- Viral Diagnostics - Virology 2024 (Austria)
- Viral Genomics and Evolution - Virology 2024 (Austria)
- Viral Immunology - Virology 2024 (Austria)
- Viral Pathogenesis - Virology 2024 (Austria)
- Viral Vaccines - Virology 2024 (Austria)